Skip to main content
OpenTrials
Completed

NCT Number: NCT04657549

Tonsil Surgery in Recurrent or Chronic Tonsillitis

Tonsil surgery is common in adults with recurrent or chronic tonsillitis. The surgical techniques include either partial or total surgical removal of the palatal tonsils (tonsillotomy, TT, and tonsillectomy, TE, respectively). The aim of this study is to find out, whether tonsil surgery improves the quality of life in these patients and whether the lighter TT is as effective as TE. Our main outcome is the disease-specific Tonsillectomy Outcome Inventory-14 (TOI-14) quality of life questionnaire score at 6 months follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lapland Central Hospital, Rovaniemi, Lapland, Finland

Loading trial locations.

About this study

Rationale

Surgical removal of palatal tonsils is among the most common ear, nose and throat operations in adults in Finland. The vast majority of these operations are done for recurrent and chronic tonsillitis. Internationally accepted guidelines for the treatment of these diseases are lacking and the indications for tonsil surgery are practice-based rather than evidence-based. The choice of the surgical technique further confuses the picture. The traditional surgical technique has been the total removal of tonsils (tonsillectomy, TE). The relatively recent introduction of partial resection of tonsils, namely tonsillotomy (TT), is suggested to have the benefits of less postoperative pain and smaller risk of post-operative hemorrhage as compared to TE. The relative efficacy of these two techniques to alleviate infective tonsillar diseases is still unclear.

Objectives

The main aim of this study is to obtain reliable evidence on, whether tonsil surgery improves the quality of life in adult patients suffering from recurrent or chronic tonsillitis, and whether the lighter TT would be as effective as TE. We will also compare the scores of a generic quality of life questionnaire as well as several other subjective and objective beneficial and harmful outcomes between the groups.

Methods

In this pragmatic multi-center randomized controlled trial, adult patients suffering from recurrent or chronic tonsillitis will be randomly allocated to three groups: tonsillotomy group (TT), tonsillectomy group (TE) and control group with watchful waiting (WW) in ratio 2:2:1. The patients in the surgical groups are blinded to the operation type (TT or TE). Our hypothesis is that both surgical treatments are more effective than watchful waiting in enhancing quality of life without significant risks (superiority assumption) and that TT is non-inferior to TE when the surgical groups are compared (non-inferiority assumption). Our principal outcome is disease-specific quality of life questionnaire score (Tonsillectomy Outcome Inventory (TOI)-14) at 6 months follow-up. We have validated this questionnaire in Finnish and explored the interpretation of the scores. Secondary outcomes have been listed in the Outcomes section.

Separate random allocation lists for the main research center (Oulu University Hospital) and for the four other centers collectively as well as for recurrent and for chronic tonsillitis will be used. Random permuted blocks is used with block size varying between 5 and 10. Based on our earlier study, the principal outcome, TOI-14 score, will most probably be left-truncated at zero and right-skewed. Therefore, both tobit-analysis and covariate analysis is used with log (1+y) transformation. The primary analysis has two phases. Firstly, the TOI-14 score in the combined surgical group (TT+TE) is compared to that in the WW group. Secondly, the score in the TT group is compared to that in the TE group. Effects will be estimated by adjusted mean differences in the log-transformed scores with 95% confidence intervals. Based on our earlier observational studies on the subject, the following covariates are included in the multivariable adjusted model: gender and baseline TOI-14 score together with stratification factors: enrolling center (Oulu vs. others) and main complaint (recurrent vs. chronic tonsillitis). In case there is missing data on the primary outcome, a multiple imputation method will be used. The analyses will be performed on an intention to treat basis. Per protocol analysis will be performed as sensitivity analysis and results from comparisons on secondary outcomes and subgroup analysis (main complaint) are used to generate hypothesis for future trials.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

The inclusion criteria are:

  • Recurrent tonsillitis episodes:
  • At least 4 episodes in the previous 12 months or at least 3 episodes in 6 months
  • Episodes are disabling, prevent normal functioning and are severe enough for the patient to seek medical attention
  • Episodes are thought to involve the palatine tonsils based on signs found during the episodes (e.g. edema, erythema, exudative tonsillitis, anterior cervical lymphadenitis)
  • No throat cultures or antigen/molecular tests to show infection with group A streptococcus are needed
  • Chronic tonsillitis:
  • Recurrent or chronic throat pain for at least 6 months
  • At least one symptom or sign that indicate that symptoms originate from the palatal tonsils (disturbing tonsil stones, halitosis, anterior cervical lymphadenitis, tonsillar exudates, abnormal tonsillar crypts)
  • Symptomatic treatment has not been effective

The exclusion criteria are:

  • Age less than 18 years
  • Pregnancy
  • History of peritonsillar abscess
  • Previous illness that make prompt same-day surgery unfeasible
  • No electronic identity verification tools

Treatment and study plan

Tonsillectomy

Procedure

Tonsillectomy is done by monopolar electrocautery, bipolar scissors or cold instruments. First the mucosa of the anterior palatinal arch is incised and tonsillar capsule identified, then tonsillar tissue is removed along the capsule. Any bleeding is coagulated either with monopolar or bipolar electrocautery.

Other names: Extracapsular tonsillectomy, ECTE

Tonsillotomy

Procedure

Tonsillotomy is done using monopolar electrosurgery, bipolar scissors or coblator device. Most of the tonsillar tissue is removed, exceeding the removal behind the line between anterior and posterior palatinal arch so that only thin layer of tonsil tissue is left over the tonsillar capsule.

Other names: Intracapsular tonsillectomy, ICTE. Subtotal/intracapsular/partial tonsillectomy, SIPT.

Primary outcomes

  1. Tonsillectomy Outcome Inventory -14 (TOI-14) follow-up score

    Time frame: At the end of five to six months follow-up

    TOI-14 is a disease-specific quality of life questionnaire for throat related symptoms in adults. TOI-14 summary scores vary between 0 and 100 with higher values indicating poorer quality of life. Analysis is described in the Detailed Description section.

Secondary outcomes

  1. 36-Item short Form Survey (SF-36, RAND-36) follow-up score

    Time frame: At the end of five to six months follow-up

    Difference in RAND-36 domains scores between groups. RAND-36 instrument produces eight individual values between 0 and 100 (one for each domain), with higher scores indicating better quality of life

  2. Proportion benefiting

    Time frame: At the end of five to six months follow-up

    Difference in proportions of patients benefiting clinically significantly from the intervention between the groups (minimum important change in TOI-14 score)

  3. Days with throat pain

    Time frame: At the end of five to six months follow-up

    Difference in the number of days patients have throat pain (severity scaled 0-10) between the groups

  4. Days with halitosis

    Time frame: At the end of five to six months follow-up

    Difference in the number of days patients have bad breath (severity scaled 0-10) between the groups

  5. Days with bleeding

    Time frame: At the end of five to six months follow-up

    Difference in the number of days patients have bleeding from the throat (severity scaled 0-10) between the groups

  6. Days with tonsil stones

    Time frame: At the end of five to six months follow-up

    Difference in the number of days patients have bothering tonsil stones (severity scaled 0-10) between the groups

  7. Days with absence from work

    Time frame: At the end of five to six months follow-up

    Difference in the number of days patients are absent from work or school due to throat symptoms between the groups

  8. Days with dexketoprofen

    Time frame: At the end of five to six months follow-up

    Difference in the number of days patients take deksketoprofen 25 mg pain medication due to throat pain between the groups

  9. Days with acetaminophen

    Time frame: At the end of five to six months follow-up

    Difference in the number of days patients take acetaminophen 1 g pain medication due to throat pain between the groups

  10. Days with oxycodone/naloxone

    Time frame: At the end of five to six months follow-up

    Difference in the number of days patients take oxycodone/naloxone 5mg/2.5mg pain medication due to throat pain between the groups

  11. Medical visits

    Time frame: At the end of five to six months follow-up

    Difference in the number of medical visit for throat symptoms between the groups

  12. Antibiotic courses

    Time frame: At the end of five to six months follow-up

    Difference in the number of antibiotic courses for throat symptoms between the groups

  13. Adverse effect-postoperative bleeding

    Time frame: At the end of five to six months follow-up

    Frequency of postoperative bleeding in the surgical groups

  14. Adverse effect - postoperative pain

    Time frame: At the end of five to six months follow-up

    Frequency of postoperative pain in the surgical groups

  15. Adverse effect - postoperative infection

    Time frame: At the end of five to six months follow-up

    Frequency of postoperative infections in the surgical groups

  16. Adverse effect - dental injury

    Time frame: At the end of five to six months follow-up

    Frequency of dental injury in the surgical groups

  17. Adverse effect -anesthetic complication

    Time frame: At the end of five to six months follow-up

    Frequency of anesthetic complication in the surgical groups

  18. Adverse effect - tightness/globus

    Time frame: At the end of five to six months follow-up

    Difference in proportions having feeling of tightness/globus in throat between the groups

  19. Adverse effect - voice problems

    Time frame: At the end of five to six months follow-up

    Difference in proportions having voice problems between the groups

  20. Adverse effect - jaw problems

    Time frame: At the end of five to six months follow-up

    Difference in proportions having mandibular joint problems between the groups

Sponsors and collaborators

Lead sponsor

Oulu University Hospital

Other

Registry information

Official study title

Partial or Total Surgical Removal of Palatal Tonsils to Change Quality of Life for Adults With Chronic or Recurrent Tonsillitis: Randomized Controlled Trial.

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Dec 8, 2020
Registry last updated
Jun 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.